BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
Keryx completes enrollment in short-term phase III efficacy study of Zerenex
Oct. 28, 2010
Two doses of Duromist oral spray show bioequivalence to Viagra tablet
Oct. 20, 2010
Amgen reviews TREAT data and proposes updates to ESA labeling
Oct. 19, 2010
Pharmalink obtains FDA orphan drug designation for PL-56
Oct. 14, 2010
Auxilium begins phase III Xiaflex studies in Peyronie's disease
Oct. 13, 2010
Recordati and Almirall launch silodosin for treatment of BPH symptoms in Spain
Oct. 11, 2010
Keryx advances phase III program for hyperphosphatemia treatment Zerenex
Oct. 4, 2010
Walter Chilcott acquires U.S. rights to Enablex from Novartis
Sep. 28, 2010
Vifor and Kissei Pharma partner to develop and market PA-21 in Japan
Sep. 27, 2010
Abbott and Reata to codevelop bardoxolone methyl for CKD
Sep. 27, 2010
Previous
1
2
…
116
117
118
119
120
121
122
123
124
…
318
319
Next
RSS